Form 8-K - Current report:
SEC Accession No. 0001193125-21-249253
Filing Date
2021-08-17
Accepted
2021-08-17 16:53:09
Documents
12
Period of Report
2021-08-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d160860d8k.htm   iXBRL 8-K 23974
  Complete submission text file 0001193125-21-249253.txt   150026

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dbtx-20210813.xsd EX-101.SCH 2895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbtx-20210813_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbtx-20210813_pre.xml EX-101.PRE 11862
5 EXTRACTED XBRL INSTANCE DOCUMENT d160860d8k_htm.xml XML 3477
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40030 | Film No.: 211183473
SIC: 2834 Pharmaceutical Preparations